APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allergic Rhinitis Decongestants Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Allergic Rhinitis Decongestants Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchAllergic Rhinitis Decongestants Drug Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Allergic Rhinitis Decongestants Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Allergic Rhinitis Decongestants Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allergic Rhinitis Decongestants Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Allergic Rhinitis Decongestants Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Allergic Rhinitis Decongestants Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Allergic Rhinitis Decongestants Drug include Shenzhen Daphne, Johnson & Johnson, Nanjing Tianlang, Nanjing Haijing, Mingsheng Pharma, Dandong Pharma, Procter & Gamble, Bayer and Foundation Consumer Brands, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Allergic Rhinitis Decongestants Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Allergic Rhinitis Decongestants Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Allergic Rhinitis Decongestants Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Allergic Rhinitis Decongestants Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Allergic Rhinitis Decongestants Drug Segment by Company

Shenzhen Daphne

Johnson & Johnson

Nanjing Tianlang

Nanjing Haijing

Mingsheng Pharma

Dandong Pharma

Procter & Gamble

Bayer

Foundation Consumer Brands

B.F. Ascher & Company

Allergic Rhinitis Decongestants Drug Segment by Type

Nasal Spray

Tablet

Allergic Rhinitis Decongestants Drug Segment by Application

Clinic

Hospital

Pharmacy Retail

Other

Allergic Rhinitis Decongestants Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergic Rhinitis Decongestants Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergic Rhinitis Decongestants Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergic Rhinitis Decongestants Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Allergic Rhinitis Decongestants Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Allergic Rhinitis Decongestants Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Allergic Rhinitis Decongestants Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Allergic Rhinitis Decongestants Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Allergic Rhinitis Decongestants Drug Industry Trends Table 2. Allergic Rhinitis Decongestants Drug Industry Drivers Table 3. Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges Table 4. Allergic Rhinitis Decongestants Drug Industry Restraints Table 5. Global Allergic Rhinitis Decongestants Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Allergic Rhinitis Decongestants Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Manufacturers Table 9. Global Allergic Rhinitis Decongestants Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Allergic Rhinitis Decongestants Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Allergic Rhinitis Decongestants Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Allergic Rhinitis Decongestants Drug Manufacturers, Product Type & Application Table 13. Global Allergic Rhinitis Decongestants Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Allergic Rhinitis Decongestants Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nasal Spray Table 17. Major Manufacturers of Tablet Table 18. Global Allergic Rhinitis Decongestants Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 20. Global Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 21. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2026) Table 22. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2027-2032) Table 23. Global Allergic Rhinitis Decongestants Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (k units) Table 25. Global Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (k units) Table 26. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2026) Table 27. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Pharmacy Retail Table 31. Major Manufacturers of Other Table 32. Global Allergic Rhinitis Decongestants Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 34. Global Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 35. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2026) Table 36. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2027-2032) Table 37. Global Allergic Rhinitis Decongestants Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (k units) Table 39. Global Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (k units) Table 40. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2026) Table 41. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2027-2032) Table 42. Global Allergic Rhinitis Decongestants Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Allergic Rhinitis Decongestants Drug Sales by Region (2021-2026) & (k units) Table 44. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2021-2026) Table 45. Global Allergic Rhinitis Decongestants Drug Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Allergic Rhinitis Decongestants Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 49. North America Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 50. Europe Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 52. Europe Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 59. Global Allergic Rhinitis Decongestants Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Allergic Rhinitis Decongestants Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Allergic Rhinitis Decongestants Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2021-2026) Table 63. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2027-2032) Table 64. Shenzhen Daphne Company Information Table 65. Shenzhen Daphne Business Overview Table 66. Shenzhen Daphne Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shenzhen Daphne Allergic Rhinitis Decongestants Drug Product Portfolio Table 68. Shenzhen Daphne Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Allergic Rhinitis Decongestants Drug Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Nanjing Tianlang Company Information Table 75. Nanjing Tianlang Business Overview Table 76. Nanjing Tianlang Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Nanjing Tianlang Allergic Rhinitis Decongestants Drug Product Portfolio Table 78. Nanjing Tianlang Recent Development Table 79. Nanjing Haijing Company Information Table 80. Nanjing Haijing Business Overview Table 81. Nanjing Haijing Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Nanjing Haijing Allergic Rhinitis Decongestants Drug Product Portfolio Table 83. Nanjing Haijing Recent Development Table 84. Mingsheng Pharma Company Information Table 85. Mingsheng Pharma Business Overview Table 86. Mingsheng Pharma Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Mingsheng Pharma Allergic Rhinitis Decongestants Drug Product Portfolio Table 88. Mingsheng Pharma Recent Development Table 89. Dandong Pharma Company Information Table 90. Dandong Pharma Business Overview Table 91. Dandong Pharma Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Dandong Pharma Allergic Rhinitis Decongestants Drug Product Portfolio Table 93. Dandong Pharma Recent Development Table 94. Procter & Gamble Company Information Table 95. Procter & Gamble Business Overview Table 96. Procter & Gamble Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Procter & Gamble Allergic Rhinitis Decongestants Drug Product Portfolio Table 98. Procter & Gamble Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bayer Allergic Rhinitis Decongestants Drug Product Portfolio Table 103. Bayer Recent Development Table 104. Foundation Consumer Brands Company Information Table 105. Foundation Consumer Brands Business Overview Table 106. Foundation Consumer Brands Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Foundation Consumer Brands Allergic Rhinitis Decongestants Drug Product Portfolio Table 108. Foundation Consumer Brands Recent Development Table 109. B.F. Ascher & Company Company Information Table 110. B.F. Ascher & Company Business Overview Table 111. B.F. Ascher & Company Allergic Rhinitis Decongestants Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. B.F. Ascher & Company Allergic Rhinitis Decongestants Drug Product Portfolio Table 113. B.F. Ascher & Company Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Allergic Rhinitis Decongestants Drug Distributors List Table 117. Allergic Rhinitis Decongestants Drug Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Allergic Rhinitis Decongestants Drug Product Image Figure 2. Global Allergic Rhinitis Decongestants Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allergic Rhinitis Decongestants Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Allergic Rhinitis Decongestants Drug Sales (2021-2032) & (k units) Figure 5. Global Allergic Rhinitis Decongestants Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Allergic Rhinitis Decongestants Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nasal Spray Image Figure 9. Tablet Image Figure 10. Global Allergic Rhinitis Decongestants Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Allergic Rhinitis Decongestants Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2032) Figure 13. Global Allergic Rhinitis Decongestants Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Allergic Rhinitis Decongestants Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Pharmacy Retail Image Figure 19. Other Image Figure 20. Global Allergic Rhinitis Decongestants Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Allergic Rhinitis Decongestants Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2032) Figure 23. Global Allergic Rhinitis Decongestants Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Allergic Rhinitis Decongestants Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 40. China Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Allergic Rhinitis Decongestants Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Allergic Rhinitis Decongestants Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Allergic Rhinitis Decongestants Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Allergic Rhinitis Decongestants Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Tablet
Applications
  • Clinic
  • Hospital
  • Pharmacy Retail
  • Other
Companies covered
  • Shenzhen Daphne
  • Johnson & Johnson
  • Nanjing Tianlang
  • Nanjing Haijing
  • Mingsheng Pharma
  • Dandong Pharma
  • Procter & Gamble
  • Bayer
  • Foundation Consumer Brands
  • B.F. Ascher & Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Allergic Rhinitis Decongestants Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Allergic Rhinitis Decongestants Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Allergic Rhinitis Decongestants Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Allergic Rhinitis Decongestants Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Allergic Rhinitis Decongestants Drug Market Dynamics
  1. 2.1 Allergic Rhinitis Decongestants Drug Industry Trends
  2. 2.2 Allergic Rhinitis Decongestants Drug Industry Drivers
  3. 2.3 Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges
  4. 2.4 Allergic Rhinitis Decongestants Drug Industry Restraints
3 Allergic Rhinitis Decongestants Drug Market by Manufacturers
  1. 3.1 Global Allergic Rhinitis Decongestants Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Allergic Rhinitis Decongestants Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Allergic Rhinitis Decongestants Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Allergic Rhinitis Decongestants Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Allergic Rhinitis Decongestants Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Allergic Rhinitis Decongestants Drug Manufacturers, Product Type & Application
  7. 3.7 Global Allergic Rhinitis Decongestants Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Allergic Rhinitis Decongestants Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Allergic Rhinitis Decongestants Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Allergic Rhinitis Decongestants Drug Tier 1, Tier 2, and Tier 3
4 Allergic Rhinitis Decongestants Drug Market by Type
  1. 4.1 Allergic Rhinitis Decongestants Drug Type Introduction
  2. 4.1.1 Nasal Spray
  3. 4.1.2 Tablet
  4. 4.2 Global Allergic Rhinitis Decongestants Drug Sales by Type
  5. 4.2.1 Global Allergic Rhinitis Decongestants Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Allergic Rhinitis Decongestants Drug Revenue by Type
  9. 4.3.1 Global Allergic Rhinitis Decongestants Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2032)
5 Allergic Rhinitis Decongestants Drug Market by Application
  1. 5.1 Allergic Rhinitis Decongestants Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy Retail
  5. 5.1.4 Other
  6. 5.2 Global Allergic Rhinitis Decongestants Drug Sales by Application
  7. 5.2.1 Global Allergic Rhinitis Decongestants Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Allergic Rhinitis Decongestants Drug Revenue by Application
  11. 5.3.1 Global Allergic Rhinitis Decongestants Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2032)
6 Global Allergic Rhinitis Decongestants Drug Sales by Region
  1. 6.1 Global Allergic Rhinitis Decongestants Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Allergic Rhinitis Decongestants Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Allergic Rhinitis Decongestants Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Allergic Rhinitis Decongestants Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Allergic Rhinitis Decongestants Drug Revenue by Region
  1. 7.1 Global Allergic Rhinitis Decongestants Drug Revenue by Region
  2. 7.1.1 Global Allergic Rhinitis Decongestants Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Allergic Rhinitis Decongestants Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Allergic Rhinitis Decongestants Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Allergic Rhinitis Decongestants Drug Revenue (2021-2032)
  8. 7.2.2 North America Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Allergic Rhinitis Decongestants Drug Revenue (2021-2032)
  11. 7.3.2 Europe Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Allergic Rhinitis Decongestants Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Allergic Rhinitis Decongestants Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen Daphne
  2. 8.1.1 Shenzhen Daphne Company Information
  3. 8.1.2 Shenzhen Daphne Business Overview
  4. 8.1.3 Shenzhen Daphne Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen Daphne Allergic Rhinitis Decongestants Drug Product Portfolio
  6. 8.1.5 Shenzhen Daphne Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Allergic Rhinitis Decongestants Drug Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Nanjing Tianlang
  14. 8.3.1 Nanjing Tianlang Company Information
  15. 8.3.2 Nanjing Tianlang Business Overview
  16. 8.3.3 Nanjing Tianlang Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Tianlang Allergic Rhinitis Decongestants Drug Product Portfolio
  18. 8.3.5 Nanjing Tianlang Recent Developments
  19. 8.4 Nanjing Haijing
  20. 8.4.1 Nanjing Haijing Company Information
  21. 8.4.2 Nanjing Haijing Business Overview
  22. 8.4.3 Nanjing Haijing Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nanjing Haijing Allergic Rhinitis Decongestants Drug Product Portfolio
  24. 8.4.5 Nanjing Haijing Recent Developments
  25. 8.5 Mingsheng Pharma
  26. 8.5.1 Mingsheng Pharma Company Information
  27. 8.5.2 Mingsheng Pharma Business Overview
  28. 8.5.3 Mingsheng Pharma Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mingsheng Pharma Allergic Rhinitis Decongestants Drug Product Portfolio
  30. 8.5.5 Mingsheng Pharma Recent Developments
  31. 8.6 Dandong Pharma
  32. 8.6.1 Dandong Pharma Company Information
  33. 8.6.2 Dandong Pharma Business Overview
  34. 8.6.3 Dandong Pharma Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dandong Pharma Allergic Rhinitis Decongestants Drug Product Portfolio
  36. 8.6.5 Dandong Pharma Recent Developments
  37. 8.7 Procter & Gamble
  38. 8.7.1 Procter & Gamble Company Information
  39. 8.7.2 Procter & Gamble Business Overview
  40. 8.7.3 Procter & Gamble Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Procter & Gamble Allergic Rhinitis Decongestants Drug Product Portfolio
  42. 8.7.5 Procter & Gamble Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Allergic Rhinitis Decongestants Drug Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Foundation Consumer Brands
  50. 8.9.1 Foundation Consumer Brands Company Information
  51. 8.9.2 Foundation Consumer Brands Business Overview
  52. 8.9.3 Foundation Consumer Brands Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Foundation Consumer Brands Allergic Rhinitis Decongestants Drug Product Portfolio
  54. 8.9.5 Foundation Consumer Brands Recent Developments
  55. 8.10 B.F. Ascher & Company
  56. 8.10.1 B.F. Ascher & Company Company Information
  57. 8.10.2 B.F. Ascher & Company Business Overview
  58. 8.10.3 B.F. Ascher & Company Allergic Rhinitis Decongestants Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 B.F. Ascher & Company Allergic Rhinitis Decongestants Drug Product Portfolio
  60. 8.10.5 B.F. Ascher & Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Allergic Rhinitis Decongestants Drug Value Chain Analysis
  2. 9.1.1 Allergic Rhinitis Decongestants Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Allergic Rhinitis Decongestants Drug Production Mode & Process
  6. 9.2 Allergic Rhinitis Decongestants Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Allergic Rhinitis Decongestants Drug Distributors
  9. 9.2.3 Allergic Rhinitis Decongestants Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst